Kathrin Scheckenbach

2.1k citations

64 papers · 1.4k indexed · h-index 25

Co-authors: Martin Wagenmann H. Bier Vera Balz Thomas K. Hoffmann Helmut Hanenberg Ulrike Bockmühl Karl Götte Adam Chaker
Topics: Head and Neck Cancer Studies (16 papers)Cancer-related Molecular Pathways (11 papers)Allergic Rhinitis and Sensitization (7 papers)
Cited by: Otorhinolaryngology Oncology Immunology and Allergy
Journals: PLoS ONE Journal of Allergy and Clinical Immunology Human Molecular Genetics
Partner nations: Germany United States Netherlands

In The Last Decade

Kathrin Scheckenbach

60 papers receiving 1.3k citations

Peers

Countries citing papers authored by Kathrin Scheckenbach

Since Specialization

Citations

This map shows the geographic impact of Kathrin Scheckenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Scheckenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Scheckenbach more than expected).

Fields of papers citing papers by Kathrin Scheckenbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin Scheckenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Scheckenbach. The network helps show where Kathrin Scheckenbach may publish in the future.

Co-authorship network of co-authors of Kathrin Scheckenbach

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin Scheckenbach. A scholar is included among the top collaborators of Kathrin Scheckenbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin Scheckenbach. Kathrin Scheckenbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ferroptosis-Related Gene Signatures: Prognostic Role in HPV-Positive Oropharyngeal Squamous Cell Carcinoma 2025 ·Cancers ·(unknown),(unknown),Marta Lucchetta,Stefano Cavalieri,Ruud H. Brakenhoff,(unknown),Kathrin Scheckenbach,Tito Poli,Lisa Licitra,(unknown)	2
2	Prognostic gene expression signatures for HPV-negative head and neck squamous cell carcinoma 2025 ·Radiotherapy and Oncology ·Stefano Cavalieri,Ruud H. Brakenhoff,C. René Leemans,Frank Hoebers,Tito Poli,Kathrin Scheckenbach,Nicola Alessandro Iacovelli,(unknown),Ester Orlandi,Lisa Licitra,(unknown)	0
3	Recognizing cisplatin as a potential radiation recall trigger: case report and focused systematic review 2023 ·Strahlentherapie und Onkologie ·Bálint Tamaskovics,Jan Haussmann,(unknown),(unknown),Peter Arne Gerber,(unknown),Kathrin Scheckenbach,Edwin Bölke,Christiane Matuschek,Wilfried Budach	4
4	HeNeCOn: An ontology for integrative research in Head and Neck cancer 2023 ·International Journal of Medical Informatics ·(unknown),(unknown),(unknown),María Fernanda Cabrera-Umpiérrez,María Teresa Arredondo,Giuseppe Fico,Tito Poli,(unknown),(unknown),Lisa Licitra,Stefano Cavalieri,Loris De Cecco,Silvana Canevari,Kathrin Scheckenbach,Ruud H. Brakenhoff,Irene H. Nauta,Frank Hoebers,Frederik Wesseling,Annalisa Trama,Gemma Gatta	3
5	Prognostic radiomic signature for head and neck cancer: Development and validation on a multi-centric MRI dataset 2023 ·Radiotherapy and Oncology ·Marco Bologna,Valentina Corino,Stefano Cavalieri,Giuseppina Calareso,Silvia Eleonora Gazzani,Tito Poli,Marco Ravanelli,Davide Mattavelli,Pim de Graaf,Irene H. Nauta,Kathrin Scheckenbach,Lisa Licitra,Luca Mainardi	12
6	Engineering a single-chain variable fragment of cetuximab for CAR T-cell therapy against head and neck squamous cell carcinomas 2022 ·Oral Oncology ·(unknown),(unknown),(unknown),Michèle J. Hoffmann,(unknown),Alexandra Hamacher,Matthias U. Kassack,Constanze Wiek,Kathrin Scheckenbach,Helmut Hanenberg	15
7	CD44v6-targeted CAR T-cells specifically eliminate CD44 isoform 6 expressing head/neck squamous cell carcinoma cells 2021 ·Oral Oncology ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Constanze Wiek,Martin Wagenmann,Cornelia Monzel,Kathrin Scheckenbach,Helmut Hanenberg	31
8	A Prospectively Validated Prognostic Model for Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck Based on Radiomics of Computed Tomography Images 2021 ·Cancers ·Simon Keek,Frederik Wesseling,Henry C. Woodruff,Janita E. van Timmeren,Irene H. Nauta,Thomas K. Hoffmann,Stefano Cavalieri,Giuseppina Calareso,Sergey Primakov,Ralph T. H. Leijenaar,Lisa Licitra,Marco Ravanelli,Kathrin Scheckenbach,Tito Poli,Davide Lanfranco,Marije R. Vergeer,C. René Leemans,Ruud H. Brakenhoff,Frank Hoebers,Philippe Lambin	19
9	Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy 2020 ·PLoS ONE ·Simon Keek,Sebastian Sanduleanu,Frederik Wesseling,(unknown),Michiel W. M. van den Brekel,(unknown),Conchita Vens,Giuseppina Calareso,Lisa Licitra,Kathrin Scheckenbach,Marije R. Vergeer,C. René Leemans,Ruud H. Brakenhoff,Irene H. Nauta,Stefano Cavalieri,Henry C. Woodruff,Tito Poli,Ralph T. H. Leijenaar,Frank Hoebers,Philippe Lambin	35
10	Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma 2019 ·BMC Cancer ·(unknown),(unknown),Wolfgang A. Schulz,Dimo Dietrich,(unknown),Constanze Wiek,Kathrin Scheckenbach,Nadine T. Gaisa,Michèle J. Hoffmann	25
11	Mutational and Functional Analysis of FANCB as a Candidate Gene for Sporadic Head and Neck Squamous Cell Carcinomas 2018 ·Anticancer Research ·(unknown),Constanze Wiek,(unknown),(unknown),Vera Balz,Vera Okpanyi,Martin Wagenmann,Thomas K. Hoffmann,(unknown),(unknown),Jörg Schipper,Helmut Hanenberg,Kathrin Scheckenbach	6
12	Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients 2016 ·Radiotherapy and Oncology ·Christiane Matuschek,Edwin Bölke,(unknown),Kai Kammers,Ute Ganswindt,Kathrin Scheckenbach,Stephan Gripp,(unknown),Thomas K. Hoffmann,Jens Greve,Peter Arne Gerber,Klaus Orth,(unknown),Matthias Hautmann,Wilfried Budach	11
13	Emerging therapeutic options in fulminant invasive rhinocerebral mucormycosis 2009 ·Auris Nasus Larynx ·Kathrin Scheckenbach,Oliver A. Cornely,Thomas K. Hoffmann,Rainer Engers,H. Bier,Adam Chaker,(unknown),Jörg Schipper,Martin Wagenmann	55
14	A novel mechanism for anti‐EGFR antibody action involves chemokine‐mediated leukocyte infiltration 2009 ·International Journal of Cancer ·Thomas K. Hoffmann,(unknown),Enikö Sonkoly,Sven Brandau,Stephan Lang,Andor Pivarcsi,Vera Balz,Anja Müller,Bernhard Homey,Edwin Boelke,Torsten E. Reichert,U Friebe-Hoffmann,Jens Greve,Patrick J. Schuler,Kathrin Scheckenbach,Jörg Schipper,Murat Baş,Theresa L. Whiteside,H. Bier	51
15	Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma 2008 ·Oral Oncology ·Thomas K. Hoffmann,Enikö Sonkoly,U. Häuser,Anke Van Lierop,Theresa L. Whiteside,Jens Peter Klußmann,D. Häfner,Patrick J. Schuler,U Friebe-Hoffmann,Kathrin Scheckenbach,Kaisa Erjala,Reidar Grénman,Jörg Schipper,H. Bier,Vera Balz	50
16	Is there a role for the Fas-/Fas-Ligand pathway in chemoresistance of human squamous cell carcinomas of the head and neck (SCCHN)? 2008 ·Oral Oncology ·Christoph Sproll,(unknown),Thomas K. Hoffmann,Kathrin Scheckenbach,Ursula Koldovsky,Vera Balz,D. Häfner,Uwe Ramp,H. Bier	6
17	An intronic alteration of the fibroblast growth factor 10 gene causing ALSG-(aplasia of lacrimal and salivary glands) syndrome 2008 ·BMC Medical Genetics ·Kathrin Scheckenbach,Vera Balz,Martin Wagenmann,Thomas K. Hoffmann	11
18	Die epithetische Versorgung des dysmorphen Tracheostomas nach Laryngektomie 2006 ·Laryngo-Rhino-Otologie ·(unknown),(unknown),(unknown),Kathrin Scheckenbach,(unknown),(unknown)	2
19	Production of Th2-, Th1-, and regulatory cytokines in allergic rhinitis 2005 ·Journal of Allergy and Clinical Immunology ·Martin Wagenmann,Adam Chaker,Kathrin Scheckenbach	1
20	Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region 2002 ·Head & Neck ·U. Häuser,Vera Balz,Thomas E. Carey,Reidar Grénman,Anke Van Lierop,Kathrin Scheckenbach,H. Bier	43

About Kathrin Scheckenbach

Kathrin Scheckenbach is a scholar working on Otorhinolaryngology, Immunology and Allergy and Oncology, having authored 64 papers that have together received 1.4k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (16 papers), Cancer-related Molecular Pathways (11 papers) and Allergic Rhinitis and Sensitization (7 papers). The work is most often cited by research in Otorhinolaryngology (314 citations), Oncology (513 citations) and Immunology and Allergy (104 citations). Kathrin Scheckenbach has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Martin Wagenmann, H. Bier, Vera Balz, Thomas K. Hoffmann, Helmut Hanenberg, Ulrike Bockmühl, Karl Götte, Adam Chaker, Iver Petersen and Constanze Wiek. Their work appears in journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact